
Vitamin A supplements provides no vision benefit to RP patients
Research determines that taking high dose vitamin A supplements does not slow vision loss in people with retinitis pigmentosa (RP).
Search results
Research determines that taking high dose vitamin A supplements does not slow vision loss in people with retinitis pigmentosa (RP).
Biotechnology company ProQR has announced encouraging results from its phase 1/2 clinical trial of an innovative treatment for sight loss caused by faults in a specific section of the USH2A gene.
Martin started volunteering for Retina UK in 2014 after retiring as a Chartered Civil Engineer.
The BBC World Service has undertaken an investigation of unproven treatments for retinitis pigmentosa (RP) and has produced a documentary film, called Blind Faith, which is available on BBC iPlayer.
Despite the challenges of the pandemic, researchers and pharmaceutical companies are still making progress towards delivering new treatments for inherited sight loss.
Biopharmaceutical company ProQR is conducting a Phase 2/3 clinical trial (Illuminate) to measure the safety and effectiveness of RNA therapy, Sepofarsen which aims to treat Leber's Congenital Amourosis (LCA) 10.
Did you know May is National Walking Month? As part of Mental Health Awareness Week, we're exploring the power of movement.
Our monthly e-Newsletter featuring the latest updates from Retina UK.
An unmissable event for people of all ages living with varying degrees of sight loss, professionals supporting and advising VIP’s and for all businesses and other organisations wishing to improve their services for the visually impaired.
Join us for an inspiring webinar where young adults living with sight loss share their extraordinary stories and insights.